Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige   
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2578 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
2001 Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: A long-term follow-up Rabey, Jose
2011
7 4S p. S663-
1 p.
artikel
2002 Replication of LOAD GWAS Associations Carrasquillo, Minerva
2011
7 4S p. S180-S181
2 p.
artikel
2003 Reported memory complaints Szoeke, Cassandra
2011
7 4S p. S365-
1 p.
artikel
2004 Reported weight loss is associated with dementia severity in older adults from Latin America, China and India: evidence from the 1066 cross-sectional surveys Taylor, Clare
2011
7 4S p. S346-
1 p.
artikel
2005 Reporting and quality of longitudinal studies of diagnostic accuracy in mild cognitive impairment: A systematic literature review and analysis McShane, Rupert
2011
7 4S p. e7-
1 p.
artikel
2006 Requirement of active JNK for beta-amyloid deposition Mazzitelli, Sonia
2011
7 4S p. S531-
1 p.
artikel
2007 Research and development of anti-Abeta oligomers antibodies for the treatment of Alzheimer's disease Okamoto, Yasuhide
2011
7 4S p. S469-
1 p.
artikel
2008 Research consortium of amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula of Japan Kokubo, Yasumasa
2011
7 4S p. e47-
1 p.
artikel
2009 Research consortium of amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula of Japan Kokubo, Yasumasa
2011
7 4S p. S756-S757
2 p.
artikel
2010 Responders to donepezil treatment in Alzheimer's disease patients and the auditory selective attention task Ouchi, Yoshitaka
2011
7 4S p. S259-
1 p.
artikel
2011 Response of bace-1 activity and expression to leptin is suppressed in cultured fibroblasts from Alzheimer's patients Malaplate-Armand, Catherine
2011
7 4S p. S584-
1 p.
artikel
2012 Rest and task-related arterial spin labeling MRI in MCI Wolk, David
2011
7 4S p. S229-
1 p.
artikel
2013 resting and task-related functional MRI in mild cognitive impairment and Alzheimer's disease Zamboni, Giovanna
2011
7 4S p. S747-S748
2 p.
artikel
2014 Resting bold fMRI differentiates dementia with Lewy bodies vs. Alzheimer's disease Galvin, James
2011
7 4S p. e69-
1 p.
artikel
2015 Resting brain metabolic connectivity in prodromal Alzheimer's disease: Evidence for early functional disconnection–An EADC joint project. Nobili, Flavio
2011
7 4S p. S111-S112
2 p.
artikel
2016 Resting-state brain networks in women at high risk of Alzheimer's disease Anderson, Anders
2011
7 4S p. S38-
1 p.
artikel
2017 Resting State Connectivity in Posterior Cingulate and Hippocampus in Mild Alzheimer’s Mecocci, Patrizia
2011
7 4S p. S176-
1 p.
artikel
2018 Resting state connectivity in posterior cingulate and hyppocampus in mild Alzheimer's disease and mild cognitive impairment Montella, Patrizia
2011
7 4S p. S722-S723
2 p.
artikel
2019 Resting-state fMRI activity profile in prodromal Alzheimer's disease and older adults with cognitive complaints Wang, Yang
2011
7 4S p. S40-S41
2 p.
artikel
2020 Resting-state fMRI activity profile in prodromal Alzheimer's disease and older adults with cognitive complaints Wang, Yang
2011
7 4S p. S228-S229
2 p.
artikel
2021 Resting state network abnormalities in Alzheimer's disease: Beyond the default mode network Agosta, Federica
2011
7 4S p. S730-
1 p.
artikel
2022 Resting-state network abnormalities in Alzheimer's disease: Beyond the default mode network Agosta, Federica
2011
7 4S p. S54-
1 p.
artikel
2023 Restoration of home cage activity in Tg2576 mice by immunotherapy with the Ab-oligomer selective antibody A-887755 Relo, Ana
2011
7 4S p. S772-
1 p.
artikel
2024 Rest regulates dyrk1a transcription in a negative feedback loop Sun, Xiulian
2011
7 4S p. S200-
1 p.
artikel
2025 Results from dense SNP genotyping of the 9q22-q31 CRI in the NIMH and NCRAD AD cohorts Perry, Rodney
2011
7 4S p. S200-
1 p.
artikel
2026 Results of integrated mental and physical rehabilitation in elders with memory complaints and mobility problems: A case control study Senanarong, Vorapun
2011
7 4S p. S788-
1 p.
artikel
2027 Resveratrol improves cognitive function and shows anti depressant-like effect in mice by increasing production of insulin-like growth factor-I in the hippocampus Harada, Naoaki
2011
7 4S p. S96-S97
2 p.
artikel
2028 Retinal vascular parameters as biomarkers for Alzheimer's disease Frost, Shaun
2011
7 4S p. S136-
1 p.
artikel
2029 Retinoid-based therapy of Alzheimer's disease A proof of mechanism study Endres, Kristina
2011
7 4S p. S458-S459
2 p.
artikel
2030 Retinopathy and risk of incident dementia over ten years Exalto, Lieza
2011
7 4S p. S297-
1 p.
artikel
2031 RETRACTED: Genome-wide assessment of copy number variations in early-onset Alzheimer's disease Hooli, Basavaraj
2011
7 4S p. S94-
1 p.
artikel
2032 Retrograde Transport of APP to the TGN is Retromer Mediated and Dependent on S655 Phosphorylation Cruz e Silva, Odete da
2011
7 4S p. S282-S283
2 p.
artikel
2033 Reversible dementia as first symptom of multiple myeloma: A case report Markou, Sofia
2011
7 4S p. S17-
1 p.
artikel
2034 Revised diagnostic criteria for Alzheimer's disease: impact of different supportive biomarkers on early diagnosis Fellgiebel, Andreas
2011
7 4S p. S533-S534
2 p.
artikel
2035 Revised estimates of incidence and risk factors for amyloid related imaging abnormalities (ARIA) in the phase 2 studies of bapineuzumab for mild-to-moderate Alzheimer's disease Sperling, Reisa
2011
7 4S p. e64-
1 p.
artikel
2036 RGS-14(414) gene delivery into brain area V2 induces both the recovery and prevention of recognition memory in ageing and Alzheimer's disease Navarro-Lobato, Irene
2011
7 4S p. e60-
1 p.
artikel
2037 Rheumatoid arthritis at midlife and the risk of cognitive impairment two decades later: A population-based study Wallin, Karin
2011
7 4S p. S693-
1 p.
artikel
2038 Rho gtpases as neuroimmunomodulatory targets Galea, Elena
2011
7 4S p. S812-
1 p.
artikel
2039 Ribosomal Genes Activity, Apolipoprotein-E and Interleukin-6 Polymorphisms in Alzheimer’s Disease Rasmussen, Lucas
2011
7 4S p. S193-
1 p.
artikel
2040 Risk factors for primary brain atrophy, a common cause of dementia White, Lon
2011
7 4S p. S373-
1 p.
artikel
2041 Risk factors for severe dementia from a population-based sample of incident Alzheimer's Disease: The Cache County Dementia Progression Study. Rabins, Peter
2011
7 4S p. S356-
1 p.
artikel
2042 Risk For Alzheimer's Associated With A Copy Number Variation In The Complement Receptor 1 Increasing C3b/C4b Binding Sites Brouwers, Nathalie
2011
7 4S p. S94-
1 p.
artikel
2043 Risk of Falls Among Older Adults with Preclinical Alzheimer’s Disease Stark, Susan
2011
7 4S p. S176-
1 p.
artikel
2044 Rivastigmine treatment in Parkinson's disease dementia: Short-term cholinergic effects are correlated with six-month treatment response Adler, Georg
2011
7 4S p. S776-
1 p.
artikel
2045 Rivermead behavioral memory test (RBMT) tasks predict the conversion from mild cognitive impairment to Alzheimer's disease Lopes, Katrini
2011
7 4S p. S253-
1 p.
artikel
2046 ROI-based diffusion tensor analysis for the differential diagnosis of mild cognitive impairment and Alzheimer's disease Juh, Rahyeong
2011
7 4S p. S51-
1 p.
artikel
2047 Role of astroglial glycolysis in apolipoprotein E lipidation and secretion Patil, Sachin
2011
7 4S p. S662-
1 p.
artikel
2048 Role of caregiver in subject's compliance with treatment Messick, Viviana
2011
7 4S p. S645-
1 p.
artikel
2049 Role of chaperone-mediated autophagy in Huntington's disease Qi, Lin
2011
7 4S p. S761-
1 p.
artikel
2050 Role of chemokine receptor CX3CR1 in Alzheimer's transgenic mice Fuhrmann, Martin
2011
7 4S p. S564-
1 p.
artikel
2051 Role of GSK-3 activation in Alzheimer's-like memory impairment Zhu, Ling-Qiang
2011
7 4S p. S588-
1 p.
artikel
2052 Role of Inflammation and gliosis in amyloid beta-induced retinal degeneration Mascarelli, Frédéric
2011
7 4S p. S416-
1 p.
artikel
2053 Role of mTOR in tau translation and phosphorylation in SH-SY5Y cell Tang, Zhi
2011
7 4S p. S557-
1 p.
artikel
2054 Role of OLR1 and Its Regulating hsa-miR369-3p in Alzheimer’s Disease: Genetic and Expression Analysis Galimberti, Daniela
2011
7 4S p. S185-
1 p.
artikel
2055 Role of PICALM in APP internalization, Abeta production and plaque pathogenesis Cirrito, John
2011
7 4S p. S104-
1 p.
artikel
2056 Role of RCAN1, a gene involved in the adaptation to oxidative stress, in Alzheimer's pathology Lloret, Ana
2011
7 4S p. S575-
1 p.
artikel
2057 Role of The Immune System and Inflammatory Response In The Aetiology of Alzheimer's Disease Williams, Julie
2011
7 4S p. S285-
1 p.
artikel
2058 Role of the nested genes ALZAS and ALZAS-1 in Alzheimer's disease Gano, Christin
2011
7 4S p. S136-S137
2 p.
artikel
2059 Role of the PKR-eIF2α pathway in BACE1 levels Relevance in Alzheimer's disease Mouton-Liger, François
2011
7 4S p. S392-
1 p.
artikel
2060 Roles of Id1 in Aβ-induced cell cycle re-entry in postmitotic neurons Huang, Chao-Tzu
2011
7 4S p. S406-
1 p.
artikel
2061 Roles of SNX family members in neurodegenerative diseases Zhang, Yun-wu
2011
7 4S p. S572-S573
2 p.
artikel
2062 S-adenosylmethionine and Superoxide-dismutase are effective in amyloidosis reduction in TgCRND8 mice Fuso, Andrea
2011
7 4S p. S478-S479
2 p.
artikel
2063 Safety and efficacy of galantamine (Er) in the treatment of mild to moderate Alzheimer's disease in daily routine practice Stokin, Gorazd
2011
7 4S p. S789-S790
2 p.
artikel
2064 Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease Salloway, Stephen
2011
7 4S p. S472-
1 p.
artikel
2065 Safety and pharmacokinetics of CHF5074, a novel gamma-secretase modulator, after multiple oral administrations to healthy humans Imbimbo, Bruno
2011
7 4S p. S462-
1 p.
artikel
2066 Safety and tolerability of active immunotherapy cad106 in two phase ii studies in Alzheimer's patients Orgogozo, Jean-Marc
2011
7 4S p. S470-
1 p.
artikel
2067 Safety and tolerability of BMS-708163 in a phase II study in mild-to-moderate Alzheimer's disease Salloway, Stephen
2011
7 4S p. S695-S696
2 p.
artikel
2068 Safety, tolerability and pharmacokinetics of single-ascending doses of bapineuzumab in Japanese patients with mild-to-moderate Alzheimer's disease Arai, Heii
2011
7 4S p. S776-S777
2 p.
artikel
2069 Salvia sahendica protects against apoptosis by interfering intrinsic pathway and reducing caspase-mediated PARP activation in vitro and in vivo Alamdari, Shabnam Zeighami
2011
7 4S p. S618-
1 p.
artikel
2070 sAPP-alpha modulates gamma-secretase processing of APP Hou, Huayan
2011
7 4S p. S402-S403
2 p.
artikel
2071 sAPP-α and sApp-β levels in Alzheimer's disease, Lewy body and Parkinson's disease dementia patients and their correlation with clinical diagnosis Mulugeta, Ezra
2011
7 4S p. S324-
1 p.
artikel
2072 Scaffolding protein RanBP9 potently disrupts focal adhesion signaling and neurogenesis Woo, Jung A.
2011
7 4S p. S530-
1 p.
artikel
2073 Screening method of Amyloid β oligomerization inhibitors using a novel FRET probe Ishikawa, Taizo
2011
7 4S p. S462-
1 p.
artikel
2074 Scyllo-inositol rescue of cerebrovascular deficits in TgCRND8 mice McLaurin, JoAnne
2011
7 4S p. e61-
1 p.
artikel
2075 Searching for Novel Korean Alzheimer’s Disease Mutations Bagyinszky, Eva
2011
7 4S p. S178-
1 p.
artikel
2076 γ-secretase composition and cellular trafficking Meckler, Xavier
2011
7 4S p. S578-
1 p.
artikel
2077 γ-Secretase conformational changes in the Alzheimer's Disease brain Wahlster, Lara
2011
7 4S p. S578-S579
2 p.
artikel
2078 Secretion and autophagy-dependent lysosomal sequestration of Aβ are unsuccessful rescue responses to proteasome inhibition Agholme, Lotta
2011
7 4S p. S561-
1 p.
artikel
2079 Seed-based characterization of intrinsic connectivity networks for distinguishing dementia Jones, David
2011
7 4S p. S339-S340
2 p.
artikel
2080 Seed-based characterization of intrinsic connectivity networks for distinguishing dementia Jones, David
2011
7 4S p. S13-
1 p.
artikel
2081 Seing what Alois Alzheimer Couldn’t See: The Utility of Neuroimaging in Tracking the Progression of Alzheimer's Disease and the Chronology of Events Chetelat, Gaël
2011
7 4S p. S278-
1 p.
artikel
2082 Seizures in families with Alzheimer's disease Nervi, Angela
2011
7 4S p. S358-S359
2 p.
artikel
2083 Selective Apolipoprotein E-derived peptides enhance Aβ42-α7 neuronal nicotinic acetylcholine receptors interaction Wang, Hoau-Yan
2011
7 4S p. S581-
1 p.
artikel
2084 Self-Rated Health and Risk of Incident Dementia: A Community-Based Elderly Cohort, the 3C Study Montlahuc, Claire
2011
7 4S p. S604-
1 p.
artikel
2085 Semantic clustering and hippocampal atrophy in mild cognitive impairment and Alzheimer's disease Hwang, Kristy
2011
7 4S p. S26-S27
2 p.
artikel
2086 Semantic clustering and hippocampal atrophy in mild cognitive impairment and Alzheimer's disease Hwang, Kristy
2011
7 4S p. S538-
1 p.
artikel
2087 Semantic impairments for Chinese-speaking persons with dementia: Category effects, pictorial effects, and their predictive power Lai, Yi-Hsiu
2011
7 4S p. S271-S272
2 p.
artikel
2088 Semantic memory impairment in Alzheimer's disease and frontotemporal dementia is associated with semantic network degradation Domoto-Reilly, Kimiko
2011
7 4S p. S734-
1 p.
artikel
2089 Semantic memory impairment in Alzheimer's disease and frontotemporal dementia is associated with semantic network degradation Domoto-Reilly, Kimiko
2011
7 4S p. S72-
1 p.
artikel
2090 Semantic processing abnormalities in MCI Goldberg, Terry
2011
7 4S p. S682-S683
2 p.
artikel
2091 Semantic verbal fluency test for animals in former alcoholics Junior, Emilio Herrera
2011
7 4S p. S440-
1 p.
artikel
2092 Semi-automatic hippocampal segmentation based on optimized hippocampal shape functions De Munck, Jan
2011
7 4S p. S714-S715
2 p.
artikel
2093 SEN1500, an inhibitor of beta-amyloid oligomer toxicity protects memory in models of Alzheimer's disease Amijee, Hozefa
2011
7 4S p. S455-
1 p.
artikel
2094 Sequence Variants of CISD2 Gene and the Risk of Alzheimer’s Disease Hsieh, Ching-Jow
2011
7 4S p. S182-
1 p.
artikel
2095 Sequence Variants of Interleukin 6 (IL-6) Gene and the Risk of Alzheimer’s Disease Chen, Shih-Yuan
2011
7 4S p. S181-
1 p.
artikel
2096 Serial position effects in Rey's auditory verbal learning test differentiate vascular dementia from Alzheimer's disease Vyhnalek, Martin
2011
7 4S p. S268-
1 p.
artikel
2097 Serotonergic blockade prevents age-related neurodegeneration in C. elegans model of Alzheimer's disease Pierce-Shimomura, Jon
2011
7 4S p. e11-
1 p.
artikel
2098 Serotonin depleted APP/PS1 mice as a model to study neuropathology in Alzheimer's dementia Severino, Maurizio
2011
7 4S p. S570-
1 p.
artikel
2099 Serum antibody biomarkers for Alzheimer's disease German, Dwight
2011
7 4S p. S137-
1 p.
artikel
2100 Serum ceramides predict incident Alzheimer's disease: The women's health and aging study (WHAS) II Mielke, Michelle
2011
7 4S p. S607-
1 p.
artikel
2101 Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals Beeri, Michal Schnaider
2011
7 4S p. S144-S145
2 p.
artikel
2102 Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease Vermeiren, Yannick
2011
7 4S p. S333-
1 p.
artikel
2103 Serum glycoproteins are new diagnostic markers of Alzheimer's disease Taniguchi, Miyako
2011
7 4S p. e16-
1 p.
artikel
2104 Serum Granulocyte Colony Stimulating Factor and Alzheimer's Disease Barber, Robert
2011
7 4S p. S313-
1 p.
artikel
2105 Serum homocysteine, holotranscobalamin, folate and cognition in the elderly: A longitudinal population-based study Hooshmand, Babak
2011
7 4S p. S354-
1 p.
artikel
2106 Serum IL-15 associated with APOE e4 genotype and Alzheimer's disease in the Cache County Memory Study Munger, Ronald
2011
7 4S p. S357-S358
2 p.
artikel
2107 Serum microglia antibodies potential diagnostic tools McRae, Amanda
2011
7 4S p. S142-
1 p.
artikel
2108 Serum nerve growth factor (NGF) level is reduced in mild cognitive impairment and Alzheimer's disease Diniz, Breno Satler
2011
7 4S p. S135-
1 p.
artikel
2109 Severe Dementia: A Protocol for Clinical Assessment Schultz, Rodrigo Rizek
2011
7 4S p. S167-
1 p.
artikel
2110 Severe Mini-Mental State Examination: a brief cognitive assessment for patients with moderate and severe dementia Sales, Manuela
2011
7 4S p. S263-
1 p.
artikel
2111 Severity of cognitive impairment is correlated to levels of vitamin D Kandiah, Nagaendran
2011
7 4S p. S612-S613
2 p.
artikel
2112 Sex difference in cognitive impairment associated with diabetes-mellitus and beneficial effect of spironolactone on this cognitive decline Iwanami, Jun
2011
7 4S p. S655-
1 p.
artikel
2113 Sex hormones and TNF-alpha in men with Alzheimer's disease Birch, Brian
2011
7 4S p. S349-
1 p.
artikel
2114 sICAM-1, sVCAM-1, and MIF are not associated with cognitive impairment after stroke Ma, Lu
2011
7 4S p. S141-
1 p.
artikel
2115 Sigma non-opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications Dobson-Stone, Carol
2011
7 4S p. S201-S202
2 p.
artikel
2116 Significant association of coding (Missense) SNPs with familial LOAD based on a functional genome-wide association screen Parrado, Tony
2011
7 4S p. S361-
1 p.
artikel
2117 Significant elevation of plasma BACE in AD and MCI patients Shen, Yong
2011
7 4S p. S328-S329
2 p.
artikel
2118 Similar beta-amyloid burden in posterior cortical atrophy and Alzheimer's disease de Souza, Leonardo
2011
7 4S p. S317-
1 p.
artikel
2119 Simplified ADAS-cog: A more efficient assessment for early Alzheimer's disease Huang, Yifan
2011
7 4S p. S803-
1 p.
artikel
2120 Simvastatin promotes neuronal survival following amyloid β-induced neurotoxicity through AMP-activated protein kinase activation Lin, Chih-Li
2011
7 4S p. S389-
1 p.
artikel
2121 Single- and multiple-dose safety, tolerability and pharmacokinetics of a Novel 5HT6 receptor full antagonist (SAM-760) for the treatment of the symptoms of Alzheimer's disease in healthy young adults and elderly subjects Bell, Joanne
2011
7 4S p. S778-
1 p.
artikel
2122 Single immunization with human naturally occurring autoantibodies against beta amyloid after 24 h leads to enhanced synapse formation and restores cognitive deficits in Tg2576 mice Röskam, Stephan
2011
7 4S p. S525-S526
2 p.
artikel
2123 Site-Specific Effect of Amyloid B-Peptide (Aβ) Phosphorylation on Its Conformation and Aggregation Kumar, Sathish
2011
7 4S p. S388-
1 p.
artikel
2124 Six month follow-up or annual visit: Which is better in a memory clinic? Vellas, Bruno
2011
7 4S p. S635-S636
2 p.
artikel
2125 Sleep and DeMentia Yaffe, Kristine
2011
7 4S p. S88-
1 p.
artikel
2126 Sleep duration, sleep fragmentation, and cognitive performance in very old women Spira, Adam
2011
7 4S p. S364-S365
2 p.
artikel
2127 Sleep in Alzheimer's disease: towards an integrated research agenda Ancoli-Israel, Sonia
2011
7 4S p. S91-
1 p.
artikel
2128 Slow alpha background activity in EEG is a prevalent finding in memory clinic populations and related to biological markers and vascular lesions Kramberger, Milica G.
2011
7 4S p. S160-
1 p.
artikel
2129 Slowly progressive bucco-linguo-facial apraxia, another clinical expression of frontotemporal lobar degeneration syndromes: A case report and a review of the literature Trebbastoni, Alessandro
2011
7 4S p. S764-
1 p.
artikel
2130 Small heat shock proteins associated with extracellular Aβ induce an inflammatory reaction in cultured human cerebrovascular cells Verbeek, Marcel
2011
7 4S p. S415-
1 p.
artikel
2131 Small molecule BDNF mimetics Massa, Stephen
2011
7 4S p. S490-
1 p.
artikel
2132 Small world network properties changes in mild cognitive impairment and early Alzheimer's disease Zhou, Yongxia
2011
7 4S p. S729-
1 p.
artikel
2133 Small-world networks in mild cognitive impairment: Graph analysis of resting-state brain functional connectivity He, Yi
2011
7 4S p. S213-
1 p.
artikel
2134 Smell identification test as a progression marker in Alzheimer's disease Velayudhan, Latha
2011
7 4S p. S331-S332
2 p.
artikel
2135 Smoking acelerates amyloid formation and associated neurodegenerative alterations in a transgenic mouse model of alzheimerâś disease Moreno-Gonzalez, Ines
2011
7 4S p. S705-
1 p.
artikel
2136 Social cognition impaired in amyotrophic lateral sclerosis Butman, Judith
2011
7 4S p. S751-
1 p.
artikel
2137 Social marketing for minority recruitment in rural and urban settings Williams, Monique
2011
7 4S p. S443-S444
2 p.
artikel
2138 Socioeconomic deprivation and brain size: A study using the Aberdeen 1932 birth cohort. Staff, Roger
2011
7 4S p. S425-S426
2 p.
artikel
2139 Soluble amyloid precursor protein in cerebrospinal fluid as a potential biomarker of Alzheimer's disease using a new sensitive test Chasseigneaux, Stéphanie
2011
7 4S p. S132-S133
2 p.
artikel
2140 Soluble amyloid precursor protein in cerebrospinal fluid: clinical and genetic associations in Alzheimer's disease Perneczky, Robert
2011
7 4S p. S106-
1 p.
artikel
2141 Soluble beta-amyloid oligomer-selective fluorophore: histological characterization of binding to the PDAPP model and human brain Hehir, Cristina Tan
2011
7 4S p. S310-
1 p.
artikel
2142 Somatostatin interneurons are early targets in the hippocampus of APP-based Alzheimer transgenic mice Sanchez-Mejias, Elisabeth
2011
7 4S p. S526-S527
2 p.
artikel
2143 Some drug design strategies towards the enzymes involved in Alzheimer's disease Mishra, Vikash
2011
7 4S p. S658-
1 p.
artikel
2144 SORLA/LR11 regulates neuronal exocytosis through 14-3-3 adapter proteins Rohe, Michael
2011
7 4S p. S116-
1 p.
artikel
2145 Sorting Receptor Sorla Regulates Multiple Steps in Neuronal App Transport and Processing Willnow, Thomas
2011
7 4S p. S282-
1 p.
artikel
2146 Souvenir II trial - EEG and MEG de Waal, Hanneke
2011
7 4S p. S375-
1 p.
artikel
2147 Spatial cognition in healthy elderly, degenerative disease and mild cognitive impairment (MCI) patients Mitolo, Micaela
2011
7 4S p. S256-S257
2 p.
artikel
2148 Spatial memory deficits in mild cognitive impairment Koide, Reiko
2011
7 4S p. S539-S540
2 p.
artikel
2149 Spatial navigation impairment related to entorhinal cortex atrophy can serve as sensitive marker to discriminate patients with amnestic mild cognitive impairment from healthy controls Nedelska, Zuzana
2011
7 4S p. S217-
1 p.
artikel
2150 Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition Broersen, Laus
2011
7 4S p. S650-
1 p.
artikel
2151 Specific anti-PrP mucosal and systemic response in white tail deer vaccinated with attenuated salmonella expressing deer PrP Wisniewski, Thomas
2011
7 4S p. S687-S688
2 p.
artikel
2152 Specific Aβ oligomers and the tau/Aβ42 ratio correlate in lumbar puncture CSF Handoko, Maureen
2011
7 4S p. e5-e6
nvt p.
artikel
2153 Specific Memory Complaint: Already 8 Years Before DLFT Converting (Cohort PreAL) Mornas, Aurelie Richard
2011
7 4S p. S170-
1 p.
artikel
2154 Specific nutrients to increase availability of components involved in neuronal membrane synthesis van Wijk, Nick
2011
7 4S p. S665-S666
2 p.
artikel
2155 Specific semantic memory deficits and neurofunctional alterations in Mild Cognitive Impairment Gardini, Simona
2011
7 4S p. S537-
1 p.
artikel
2156 Speech errors in Alzheimer's disease Cera, Maysa
2011
7 4S p. S240-
1 p.
artikel
2157 Sphingomyelin is elevated in cerebrospinal fluid of Alzheimer's disease patients Kosicek, Marko
2011
7 4S p. S140-
1 p.
artikel
2158 Spine pathology in down's syndrome and Alzheimer's disease Torres, Maria
2011
7 4S p. S708-
1 p.
artikel
2159 Spouse caregivers of the persons with Alzheimer's disease often suffer depression which influences their quality of life: Kuopio ALSOVA study Välimäki, Tarja
2011
7 4S p. S435-
1 p.
artikel
2160 SR-BI regulates perivascular macrophages and modifies Alzheimer's-like pathology in an Alzheimer mouse model Georgopoulos, Spiros
2011
7 4S p. S520-
1 p.
artikel
2161 Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering Dubnovitsky, Anatoly
2011
7 4S p. e21-e22
nvt p.
artikel
2162 Stabilization of protein prenylation is an emerging approach to the understanding and utilization of metabolic processes to reveal preclinical pathologic changes of Alzheimer's disease Ivan Fedoriv,
2011
7 4S p. S153-S154
2 p.
artikel
2163 Stages of granulovacuolar degeneration and its relation to Alzheimer's disease Thal, Dietmar
2011
7 4S p. S708-
1 p.
artikel
2164 Staging Dementia with ADL: A Proxy-Reported Outcome? Jonas, Christina
2011
7 4S p. S175-
1 p.
artikel
2165 Standardization of the eyes test in normal adult subjects Roman, Fabian
2011
7 4S p. S448-
1 p.
artikel
2166 Statin use and incident dementia and Alzheimer's disease in elderly African-Americans Hake, Ann Marie
2011
7 4S p. S511-S512
2 p.
artikel
2167 Stem cell factor plasma levels predict cognitive decline in Alzheimer's disease patients Laske, Christoph
2011
7 4S p. S140-S141
2 p.
artikel
2168 Stimulation of endocannabinoid receptors is required for reduction of neuroinflammation and restoration of neurogenesis in the aged brain Bardou, Isabelle
2011
7 4S p. S649-
1 p.
artikel
2169 S.Tofhla in Mild Alzheimer's Disease and Amnestic MCI Patients as a Measure of Functional Literacy Oliveira, Maira
2011
7 4S p. S258-
1 p.
artikel
2170 Strengthening Communication and Cooperation Between Family and Formal Caregivers: A Training Concept for Dementia Caregivers (QUADEM) Krause, Katharina
2011
7 4S p. S291-S292
2 p.
artikel
2171 Stressful and non-stressful testing environments in relation to hippocampal volume, stress hormone levels, and memory performance among young and older adults Sindi, Shireen
2011
7 4S p. S425-
1 p.
artikel
2172 Stressful life events and the outcome of dementia Reich, Edgardo
2011
7 4S p. S444-
1 p.
artikel
2173 Stress granules and Alzheimer's disease: Colocalization with tau pathology Wolozin, Benjamin
2011
7 4S p. S507-
1 p.
artikel
2174 Striatal amyloid plaque density predicts braak neurofibrillary tangle stage and clinicopathological Ad: Implications for amyloid imaging Beach, Thomas
2011
7 4S p. S712-S713
2 p.
artikel
2175 Structural and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein Dahms, Sven
2011
7 4S p. e32-
1 p.
artikel
2176 Structural and molecular changes along the continuum of Alzheimer's disease Ossenkoppele, Rik
2011
7 4S p. S77-
1 p.
artikel
2177 Structural correlates of CSF Abeta1-42 in controls, mild cognitive impairment and Alzheimer's disease Manning, Emily
2011
7 4S p. S31-
1 p.
artikel
2178 Structural MRI biomarker qualification Jack, Clifford
2011
7 4S p. S810-
1 p.
artikel
2179 Study of phonemic and semantic verbal fluencies in patients with Alzheimer's disease Herrera Jr., Emílio
2011
7 4S p. S247-
1 p.
artikel
2180 Subcortical Ischemic Cerebrovascular Disease in a Cohort of Oldest-Old: The PIETÀ Study Caramelli, Paulo
2011
7 4S p. S171-S172
2 p.
artikel
2181 Subfield-specific changes in the hippocampus of an Alzheimer's disease mouse model detected by diffusion tensor imaging Venkatasubramanian, Palamadai
2011
7 4S p. S226-
1 p.
artikel
2182 Subfield-specific changes in the hippocampus of an Alzheimer's mouse model detected by diffusion tensor imaging Venkatasubramanian, Palamadai
2011
7 4S p. S39-
1 p.
artikel
2183 Subjective complaint and cognitive aging Tripodis, Yorghos
2011
7 4S p. S551-
1 p.
artikel
2184 Subjective complaint and cognitive aging Tripodis, Yorghos
2011
7 4S p. e73-e74
nvt p.
artikel
2185 Subjective Memory Complaints and Cognitive Tests in the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) Zhang, Ping
2011
7 4S p. S170-
1 p.
artikel
2186 Subjective memory complaints represent a distinct entity that is associated with structural changes in the hippocampus Fortea, Juan
2011
7 4S p. S230-
1 p.
artikel
2187 Subscriber information 2011
7 4S p. A1-
1 p.
artikel
2188 Substituting placebo in long-term trials with pre-symptomatic Alzheimer's disease patients: The placebo group simulation approach (PGSA) Monsch, Andreas
2011
7 4S p. S785-
1 p.
artikel
2189 Support for Genetic Association Between Variants in PPP3R1 and MAPT and Rate of Progression of Alzheimer’s Disease Peterson, David
2011
7 4S p. S192-
1 p.
artikel
2190 Supporting Caregivers Mittelman, Mary
2011
7 4S p. e1-
1 p.
artikel
2191 Support vector machine-based classification of 18F-flutemetamol scans in Alzheimer's disease, MCI and controls: comparison with visual reads and structural MRI-based classification Vandenberghe, Rik
2011
7 4S p. S697-
1 p.
artikel
2192 Suppression of intrinsic apoptosis by synaptic released zinc Ying, Sun
2011
7 4S p. S274-
1 p.
artikel
2193 Surrogate decision and advance directives authorization to nasogastric intubation, gastrostomy, orotracheal intubation and tracheostomy in dementia: a Brazilian perspective. Neto, Ylmar Correa
2011
7 4S p. S429-S430
2 p.
artikel
2194 Surrogate decision and advance directives authorization to treatment of curable and incurable concomitant disease in dementia: a Brazilian perspective. Neto, Ylmar Correa
2011
7 4S p. S430-
1 p.
artikel
2195 Survival analysis of fixed consecutive number schedule responding in APP over-expressing transgenic rats O'Hare, Eugene
2011
7 4S p. S525-
1 p.
artikel
2196 Survival analysis of sub cortical vascular dementia in Koreans Na, Duk
2011
7 4S p. S605-
1 p.
artikel
2197 SUVN-502: A potent and selective 5-HT6 antagonist, potential drug for the treatment of Alzheimer's disease Nirogi, Ramakrishna
2011
7 4S p. S659-
1 p.
artikel
2198 SUVN-G1031, a novel selective H3 receptor antagonist in animal models of cognitive deficits Jayarajan, Pradeep
2011
7 4S p. S796-
1 p.
artikel
2199 Sydney memory and ageing study Brodaty, Henry
2011
7 4S p. S494-
1 p.
artikel
2200 Synapse disruption in AD brain: Evidence for early pathological clustering of the group I metabotropic glutamate receptor 5 Lacor, Pascale
2011
7 4S p. S703-
1 p.
artikel
2201 Synaptic long-term depression as a key to understanding the amyloid-tau connection Takashima, Akihiko
2011
7 4S p. e3-
1 p.
artikel
2202 Synaptic vesicle protein pathology in Alzheimer's disease and depression Wuwongse, Suthicha
2011
7 4S p. S587-
1 p.
artikel
2203 Synergistic Effects of Genetics and Sports Concussions in Aging De Beaumont, Louis
2011
7 4S p. S183-
1 p.
artikel
2204 Synthesis and in vitro evaluation of N-Methylpiperidinyl thioesters as a model approach to the development of cholinesterase imaging agents Macdonald, Ian
2011
7 4S p. S721-S722
2 p.
artikel
2205 Synthetic human apoE particles differentially regulate brain interstitial amyloid-beta levels Castellano, Joseph
2011
7 4S p. S383-
1 p.
artikel
2206 Tailoring occupational therapy to the individual need of patients with dementia in the patients' home settings: A prospective multi-centre randomized, controlled trial (ERGODEM) Marschner, Kira
2011
7 4S p. S784-
1 p.
artikel
2207 Tangles are distributed across two temporally and spatially distinct populations Royall, Donald
2011
7 4S p. e33-
1 p.
artikel
2208 Targeted drug delivery against beta-amyloidosis in Alzheimer's disease mouse models by using focused ultrasound technology Strobel, Lisa
2011
7 4S p. S473-
1 p.
artikel
2209 Targeted recruitment using CSF biomarkers: Implications for Alzheimer's disease trials Barnes, Josephine
2011
7 4S p. S43-
1 p.
artikel
2210 Targeted recruitment using CSF biomarkers: Implications for Alzheimer's disease trials Barnes, Josephine
2011
7 4S p. S101-S102
2 p.
artikel
2211 Targeting amyloid-beta: From molecular dynamics to synaptic function Slutsky, Inna
2011
7 4S p. S588-
1 p.
artikel
2212 Targeting hyperphosphorylated tau protein with a monoclonal antibody at an advanced stage of tau pathology improves cognition in a mouse model Boutajangout, Allal
2011
7 4S p. S480-S481
2 p.
artikel
2213 Targeting phospho-Ser422 by active Tau immunotherapy in THY-Tau22, a suitable therapeutic approach Troquier, Laetitia
2011
7 4S p. S482-S483
2 p.
artikel
2214 Targets of Aβ-induced activation of mTOR pathway in yeast model Macreadie, Ian
2011
7 4S p. S406-S407
2 p.
artikel
2215 Task-dependent fMRI abnormalities in young adults at genetic risk for early-onset Alzheimer's disease Quiroz, Yakeel
2011
7 4S p. S219-S220
2 p.
artikel
2216 Task-dependent fMRI abnormalities in young adults at genetic risk for early-onset Alzheimer's disease Quiroz, Yakeel
2011
7 4S p. S34-S35
2 p.
artikel
2217 Task-switching in a cohort of frontotemporal dementia patients Buckley, Aisling
2011
7 4S p. S239-S240
2 p.
artikel
2218 Tau and GSK-3B Brion, Jean-Pierre
2011
7 4S p. S676-
1 p.
artikel
2219 Tau autoproteolytic activity is induced by tau oligomerization Davidowitz, Eliot
2011
7 4S p. S568-
1 p.
artikel
2220 Tau cleavage by calpain: The intermediate at Mr 17kD / MW 11kD is metastable but not toxic Garg, Sarika
2011
7 4S p. S558-
1 p.
artikel
2221 Tau-dependent cytotoxicity and prion-like properties of amyloid-Beta oligomers seeded by pyroglutamate-modified amyloid-Beta Bloom, George
2011
7 4S p. S808-S809
2 p.
artikel
2222 Tau dependent spine loss in Alzheimer's disease mice Herms, Jochen
2011
7 4S p. S689-
1 p.
artikel
2223 Tau misprocessing leads to nonclassical tau secretion via vesicle release: implications for the spreading of tau lesions in Alzheimer's disease Hall, Garth
2011
7 4S p. S690-
1 p.
artikel
2224 Tauopathy in zebrafish using life imaging transgenic zebrafish Paquet, Dominik
2011
7 4S p. S87-
1 p.
artikel
2225 Tau over expression causes abnormal mitochondrial dynamics Xiachun, L.I.
2011
7 4S p. S589-
1 p.
artikel
2226 tau pathology in Young people and its progression Before Abeta Deposition Thal, Dietmar
2011
7 4S p. S492-
1 p.
artikel
2227 Tau phosphorylation and anaesthesia: A link to postoperative cognitive impairment Le Freche, Hélène
2011
7 4S p. S123-S124
2 p.
artikel
2228 Tau phosphorylation links Amyloid beta and NMDA receptor activation, implications for Alzheimer's disease Mondragon-Rodriguez, Siddhartha
2011
7 4S p. e23-e24
nvt p.
artikel
2229 Tau Reduction as a potential treatment for Alzheimer's disease, epilepsy and related disorders Mucke, Lennart
2011
7 4S p. S810-
1 p.
artikel
2230 Tau's function in different subcellular compartments Goetz, Jurgen
2011
7 4S p. S809-
1 p.
artikel
2231 TBD Chen, Zhang
2011
7 4S p. S713-S714
2 p.
artikel
2232 TBD Leone, Elsa
2011
7 4S p. S775-
1 p.
artikel
2233 T cell responses after DNA Abeta-42 trimer immunization in mice indicate the potential for safe immunotherapy for Alzheimer's disease Lambracht-Washington, Doris
2011
7 4S p. S463-
1 p.
artikel
2234 TDP-43 aggregation during chronic oxidative stress is mediated by c-Jun N-terminal kinase and can be inhibited by a potentially therapeutic metallo-complex White, Anthony
2011
7 4S p. S118-
1 p.
artikel
2235 TDP-43 and FUS have different requirements for stress granule localization Dormann, Dorothee
2011
7 4S p. S688-
1 p.
artikel
2236 Teaching Medical Students to Evaluate Cognition Using MOCA Lacombe, Guy
2011
7 4S p. S173-
1 p.
artikel
2237 Technology and participatory research attitudes in an urban naturally occurring Steinerman, Joshua
2011
7 4S p. S678-
1 p.
artikel
2238 Telomere Length Shortening in Alzheimer’s Disease Honig, Lawrence
2011
7 4S p. S288-
1 p.
artikel
2239 Temporal dynamics of cholinergic forebrain degeneration in healthy aging and early stages of Alzheimer's disease: Longitudinal observations Grothe, Michel
2011
7 4S p. S212-
1 p.
artikel
2240 Temporal influence of CAA on cerebrovascular and white matter integrity in parallel with cognition in Tg-SwDI mice Hoffmann, Leonie
2011
7 4S p. S711-
1 p.
artikel
2241 Temporo-ammonic pathway: A major transmission pathway for Tauopathy? Maurin, Hervé
2011
7 4S p. S587-S588
2 p.
artikel
2242 Tesamorelin, a growth hormone-releasing hormone analogue, improves cognitive function in MCI and healthy aging: Results of a randomized controlled trial Baker, Laura
2011
7 4S p. S514-
1 p.
artikel
2243 Testing mood-enhancing interventions in persons with dementia Williams, Kristine
2011
7 4S p. S646-
1 p.
artikel
2244 Testing the first-order Markov assumption in homogeneous Markov modeling of transition probabilities between cognitive states Koepsell, Thomas
2011
7 4S p. S354-S355
2 p.
artikel
2245 Testing the new diagnostic criteria for Preclinical Alzheimer's Disease: MRI biomarker of Alzheimer's disease-related atrophy in cognitively normal individuals predicts cognitive decline Dickerson, Brad
2011
7 4S p. S25-
1 p.
artikel
2246 Testing the new diagnostic criteria for Preclinical Alzheimer’s disease: MRI biomarker of Alzheimer’s disease-related atrophy in cognitively normal individuals predicts cognitive decline Dickerson, Brad
2011
7 4S p. S210-
1 p.
artikel
2247 Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster model of Alzheimer's Disease Costa, Rita
2011
7 4S p. S458-
1 p.
artikel
2248 Test-Retest Reliability of the MMSE, ADAS-Cog, and executive function tests in a phase II mild to moderate Alzheimer's disease study Kingery, Lisle
2011
7 4S p. S249-
1 p.
artikel
2249 The ability to design a proxy for consent to treatment and for voting with Alzheimer's disease: preliminary results of a multicenter study. Benisty, Sarah
2011
7 4S p. S277-
1 p.
artikel
2250 The ADGC genome browser Wang, Li-San
2011
7 4S p. S198-
1 p.
artikel
2251 The AD8 informant interview: Influence of cultural bias on reliability and diagnostic performance in early cognitive impairment (ECI) Lim, Wee Shiong
2011
7 4S p. S162-
1 p.
artikel
2252 The Alzheimer's therapeutic PBT2 achieves cognitive benefit by combining neuroprotection with neurorestoration: studies in animal models of Alzheimer's disease and Huntington's disease Cherny, Robert
2011
7 4S p. S457-
1 p.
artikel
2253 The 28-amino acid form of an APLP1-derived abeta-like peptide is a surrogate marker for Abeta42 production Okochi, Masayasu
2011
7 4S p. S675-
1 p.
artikel
2254 The Amyloid precursor protein in synaptic plasticity: A matrix approach Brayne, Carol
2011
7 4S p. S566-
1 p.
artikel
2255 The Aβ peptide conjugate vaccine, acc-001, generates n-terminal anti- Aβ antibodies in the absence of Aβ directed t-cell responses Hagen, Michael
2011
7 4S p. S460-S461
2 p.
artikel
2256 The art of Alzheimer's advocacy Platzer, Meril
2011
7 4S p. S799-S800
2 p.
artikel
2257 The association between APOE-e4 and mild cognitive impairment prevalence varies by method for defining cognitive impairment Jefferson, Angela
2011
7 4S p. e73-
1 p.
artikel
2258 The association between baseline salivary cortisol levels, Apolipoprotein ϵ4 and cognitive decline in South African Alzheimer's disease patients at one year follow-up James, Katharine
2011
7 4S p. S596-
1 p.
artikel
2259 The attitudes of Australian General practitioners to breaking the news of dementia: a qualitative and quantitative exploration Pond, Constance D.
2011
7 4S p. S164-
1 p.
artikel
2260 The biological significance of a 96 gene expression assay developed to aid the diagnosis of Alzheimer's disease Lönneborg, Anders
2011
7 4S p. S322-
1 p.
artikel
2261 The Blood-brain barrier in Alzheimer's disease Banks, William
2011
7 4S p. S807-
1 p.
artikel
2262 The blood-brain barrier in Alzheimer's disease Begley, David
2011
7 4S p. S590-
1 p.
artikel
2263 The cause of burden in caregivers of Alzheimer's disease patients Silvestre, Ana
2011
7 4S p. S431-
1 p.
artikel
2264 The 980C/G polymorphism in APH-1A promoter confers risk for Alzheimer's disease Jia, Jianping
2011
7 4S p. S199-
1 p.
artikel
2265 The changes of learning and memory abilities and insulin signal pathway on hippocampal neurons of diabetic mice Wang, Rong
2011
7 4S p. S118-
1 p.
artikel
2266 The climbing fibers in Alzheeimer's disease Baloyannis, Stavros
2011
7 4S p. S712-
1 p.
artikel
2267 The clinical, behavioral and cognitive correlates to the proportional impact of white matter hyperintensities in the patients with amnestic mild cognitive impairment in Korea Ku, Bon
2011
7 4S p. S540-
1 p.
artikel
2268 The Cognitive Correlates of Functional Status: A New Approach to Dementia Royall, Donald R.
2011
7 4S p. S175-
1 p.
artikel
2269 The cognitive function and ageing study (CFAS) II: study protocol Minett, Thais
2011
7 4S p. S370-S371
2 p.
artikel
2270 The consequences of Aβ deposition in aging and Alzheimer's disease: Results from 366 elderly subjects Rowe, Christopher
2011
7 4S p. S697-
1 p.
artikel
2271 The consequences of Aβ deposition in aging and Alzheimer's disease: results from 366 elderly subjects Rowe, Christopher
2011
7 4S p. S69-
1 p.
artikel
2272 The course of personality traits and their role in a development of mild cognitive impairment in a prospective ageing study in Germany Kuzma, Elzbieta
2011
7 4S p. S540-
1 p.
artikel
2273 The cross-sectional relationship between total and visceral adiposity and cognitive performance in elderly persons Yoon, Dae Hyun
2011
7 4S p. S619-
1 p.
artikel
2274 The CSF Aβ1-40/Aβ1-42 ratio for differential dementia diagnosis Slaets, Sylvie
2011
7 4S p. S329-
1 p.
artikel
2275 The CSF levels of Aβ42, but not tau, are fully changed already 5-10 years before onset of Alzheimer's dementia Buchhave, Peder
2011
7 4S p. e1-
1 p.
artikel
2276 The default mode network and related right hemisphere structures may be the key substrates of dementia Royall, Donald
2011
7 4S p. e20-
1 p.
artikel
2277 The 10/66 dementia research group cohort studies in middle income countries: dementia incidence and mortality in Latin America and China Prince, Martin
2011
7 4S p. S509-S510
2 p.
artikel
2278 The development of a prototype of elderly nursing post with elderly-friendly facilities and integrated health information in Depok, Indonesia Theresa, Ria Maria
2011
7 4S p. e53-
1 p.
artikel
2279 The diabetes associated protein, SorCS1 regulates APP metabolism Lane, Rachel
2011
7 4S p. S388-S389
2 p.
artikel
2280 The diabetes drug liraglutide ameliorates insulin resistance in the hippocampal formation of Alzheimer's disease (AD) cases Talbot, Konrad
2011
7 4S p. e65-
1 p.
artikel
2281 The differences of caregiver's quality of life based on degree of severity of patient dementia Nasrun, Martina Wiiwie
2011
7 4S p. S432-S433
2 p.
artikel
2282 The effectiveness of self-efficacy based memory training program for the elderly with mild cognitive impairment Han, Myeong-Il
2011
7 4S p. e77-
1 p.
artikel
2283 The effectiveness of tele-homecare for the caregiver of a dementia patient Yan, Sui-hing
2011
7 4S p. S436-S437
2 p.
artikel
2284 The effect of a cognitive enhancement training program on source memory in older adults Limbrick, Kelly
2011
7 4S p. S253-
1 p.
artikel
2285 The effect of Alzheimer's disease medication cost-share burden on treatment adherence and persistence Knoth, Russell
2011
7 4S p. S300-
1 p.
artikel
2286 The effect of apolipoprotein E polymorphism on hippocampal morphology in the patients with late-onset depression Lim, Hyun-Kook
2011
7 4S p. S53-S54
2 p.
artikel
2287 The effect of exercise on regional brain glucose metabolism in elderly adults: A randomized control trial Shimada, Hiroyuki
2011
7 4S p. S617-
1 p.
artikel
2288 The effect of formic acid treatment on aggregated Aβ Koge, Masahiro
2011
7 4S p. S140-
1 p.
artikel
2289 The effect of memantine on neuropsychiatric inventory (NPI) parallels with the reduction of caregiver burden: An analysis of an observational study in naturalistic setting Kulaksizoglu, Isin Baral
2011
7 4S p. S769-
1 p.
artikel
2290 The effect of solifenacin on cognitive function in stroke patients Park, Jin-Woo
2011
7 4S p. S616-
1 p.
artikel
2291 The effect of sub-anesthetic dose of ketamine on acquisition, consolidation and retrieval stages of water maze reference memory Moosavi, Maryam
2011
7 4S p. S115-S116
2 p.
artikel
2292 The effect of vignette activity on the neuropsychiatric behaviours expressed by individuals with dementia, living in long-term Care Marcy-Edwards, Donna
2011
7 4S p. S644-S645
2 p.
artikel
2293 The effect of VPA in presymptomatic Alzheimer's disease model mice Seo, Hyemyung
2011
7 4S p. S576-
1 p.
artikel
2294 The effects ischemic post-conditioning on expression of amyloid precursor protein in rats following cerebral ischemia and reperfusion Luo, Yumin
2011
7 4S p. S127-
1 p.
artikel
2295 The effects of a multiprofessional cognitive and functional rehabilitation program for patients with Alzheimer's disease and mild cognitive impairment Santos, Glenda
2011
7 4S p. S800-
1 p.
artikel
2296 The effects of a multiprofessional cognitive and functional rehabilitation program for patients with mild Alzheimer's disease Ortega, Luciane
2011
7 4S p. S660-S661
2 p.
artikel
2297 The effects of angiotensin II and angiotensin 1-7 in cognitive processes and oxidative stress in rats. Relevance for Alzheimer's disease Alin, Ciobica
2011
7 4S p. S112-S113
2 p.
artikel
2298 The effects of APOE4 on the rate of atrophy and Aβ deposition in asymptomatic elderly Chetelat, Gaël
2011
7 4S p. S23-
1 p.
artikel
2299 The effects of head circumference and lifetime alcohol consumption on cognitive function in the elderly Lee, Kang Soo
2011
7 4S p. e26-
1 p.
artikel
2300 The Effects of Neu-P11 on memory performance in NaN3 induced posterior cingulate cortex hypometabolism Tian, Shaowen
2011
7 4S p. S797-
1 p.
artikel
2301 The effects of psychosocial intervention to family caregivers of patients with memory impairment: A randomized controlled trial Yamada, Hiroko
2011
7 4S p. S436-
1 p.
artikel
2302 The effects of statin use on Alzheimer's disease CSF biomarkers in cognitively healthy elderly Glodzik, Lidia
2011
7 4S p. e58-
1 p.
artikel
2303 The effects of vitamin D receptor silencing on the expression of LVSCC-A1C, LVSCC-A1D, calbindin-D28k and iNOS and NGF release in cortical neurons Gezen-Ak, Duygu
2011
7 4S p. S122-S123
2 p.
artikel
2304 The evolution of Alzheimer's disease and its management: Data from the European ICTUS study Hausner, Lucrezia
2011
7 4S p. S159-S160
2 p.
artikel
2305 The experience of the patients and their caregivers regarding the disclosure of the diagnosis of Alzheimer's disease: A Belgian retrospective survey Mormont, Eric
2011
7 4S p. S639-S640
2 p.
artikel
2306 The expression of TGM2 in the Alzheimer brain is restricted to blood vessels Lund, Harald
2011
7 4S p. S707-
1 p.
artikel
2307 The Family of vps10 Receptors: Genetic Links to Alzheimer’s Disease Reitz, Christiane
2011
7 4S p. S282-
1 p.
artikel
2308 The Fast: A Brief, Practical, Comprehensive, Valid Functional Assessment for Alzheimer's Disease Staging, Diagnosis and Differential Diagnosis in the Primary Care Setting Reisberg, Barry
2011
7 4S p. S82-
1 p.
artikel
2309 The fourth element hypothesis of Alzheimer's disease pathogenesis Kuljis, Rodrigo
2011
7 4S p. S573-
1 p.
artikel
2310 The French national databank for Alzheimer's disease Le Duff, Franck
2011
7 4S p. S355-
1 p.
artikel
2311 The friendship project: Social interaction among dementia residents in long-term care Saunders, Pamela
2011
7 4S p. S626-
1 p.
artikel
2312 The gamma-secretase inhibitor BMS-708163 causes dose-dependent reductions in CSF Aβ40 levels in patients with mild-to-moderate Alzheimer's disease (AD) Albright, Charles
2011
7 4S p. S311-
1 p.
artikel
2313 The Gamma Secretase Inhibitor, BMS-708163 Increases Alpha Secretase Abeta Peptide Cleavage Fragments and Decreases the Gamma Secretase Abeta Peptide 1-34 Fragment in Cerebrospinal Fluid Portelius, Erik
2011
7 4S p. S289-
1 p.
artikel
2314 The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation Sarnico, Ilenia
2011
7 4S p. S800-S801
2 p.
artikel
2315 The Geriatric HearCare Services as an example of integrated “pathway” in case- and care management for hearing-impaired and/or demented patients Decker-Maruska, Mechthild
2011
7 4S p. S453-
1 p.
artikel
2316 The “Head turning sign” can be a clinical marker of Alzheimer's disease? Fukui, Toshiya
2011
7 4S p. S244-S245
2 p.
artikel
2317 The IMAP* project: Comparing information from different neuroimaging techniques in two cases with mild cognitive impairment Chételat, Gaël
2011
7 4S p. S23-
1 p.
artikel
2318 The IMAP* project: Comparing information from different neuroimaging techniques in two cases with mild cognitive impairment Chételat, Gaël
2011
7 4S p. S208-
1 p.
artikel
2319 The IMAP project: How does the awareness of memory deficits evolve in the course of Alzheimer's disease? Insights from its relationships to PET β-amyloid and metabolism measurements Perrotin, Audrey
2011
7 4S p. S742-S743
2 p.
artikel
2320 The IMAP* project: How does the awareness of memory deficits evolve in the course of Alzheimer's disease? Insights from its relationships to PET β-amyloid and metabolism measurements Perrotin, Audrey
2011
7 4S p. S77-S78
2 p.
artikel
2321 The IMAP* project: Relationships between cerebral and cognitive resting state activities in normal aging Mevel, Katell
2011
7 4S p. S422-S423
2 p.
artikel
2322 The IMAP* project: Relative degrees of regional grey matter atrophy, hypometabolism and β-amyloid deposition in Alzheimer's disease assessed through multimodal neuroimaging La Joie, Renaud
2011
7 4S p. S720-
1 p.
artikel
2323 The IMAP* Project: Relative Degrees of Regional Grey Matter Atrophy, Hypometabolism and B-Amyloid Deposition in Alzheimer's Disease Assessed Through Multimodal Neuroimaging La Joie, Renaud
2011
7 4S p. S2-
1 p.
artikel
2324 The IMAP project - The paradox of the posterior cingulate cortex in Alzheimer's disease: Atrophic, hypometabolic, but still able to show preserved fMRI activity during a self-related task Villain, Nicolas
2011
7 4S p. S745-S746
2 p.
artikel
2325 The IMAP∗ project: the paradox of the posterior cingulate cortex in Alzheimer's disease: Atrophic, hypometabolic, but still able to show preserved fMRI activity during a self-related task Villain, Nicolas
2011
7 4S p. S81-
1 p.
artikel
2326 The IMAP* project: white matter shrinkage in the posterior cingulum is related to atrophy in the hippocampus subiculum in healthy elderly Mézenge, Florence
2011
7 4S p. S421-S422
2 p.
artikel
2327 The impact of acute hospitalization on people with dementia: The behavior and pain (BepAid) study Sampson, Elizabeth
2011
7 4S p. S636-
1 p.
artikel
2328 The impact of a neurogenic agent, allopregnanolone, in rodent models of Alzheimer's and Parkinson's disease Wang, Junming
2011
7 4S p. S667-
1 p.
artikel
2329 The impact of depression on cognition varies by APOE4 status Dentino, Andrew
2011
7 4S p. S350-
1 p.
artikel
2330 The Impact of Genetics Associated with Age of Onset of Alzheimer’s Disease in People with Down’s Syndrome Upon Beta-Amyloid and Tau Concentrations Jones, Emma
2011
7 4S p. S187-
1 p.
artikel
2331 The impacts of LXR ligand TO901317 on amyloid-β levels and cholesterol metabolism in Niemann-Pick type C (NPC) model cells Stefulj, Jasminka
2011
7 4S p. e72-
1 p.
artikel
2332 The importance of home-and community-based services to quality of life in persons with dementia Schwartz, Lindsay
2011
7 4S p. S640-
1 p.
artikel
2333 The improvement effects of TLJN, a traditional Chinese herb, on the behavioral deficits in App transgenic mouse Hua, Qian
2011
7 4S p. S768-
1 p.
artikel
2334 The incremental effect of Alzheimer's disease on direct health care costs and utilization in a Medicaid population Mucha, Lisa
2011
7 4S p. S357-
1 p.
artikel
2335 The independent effects of white matter hyperintensity volume and cerebrospinal fluid amyloid levels on brain atrophy Barnes, Josephine
2011
7 4S p. S129-
1 p.
artikel
2336 The independent effects of white matter hyperintensity volume and cerebrospinal fluid amyloid levels on brain atrophy Barnes, Josephine
2011
7 4S p. S6-S7
2 p.
artikel
2337 The influence of beta-amyloid 1-42 on inflammatory processes and regenerative mechanisms in Alzheimer's disease Wicklund, Linn
2011
7 4S p. S416-
1 p.
artikel
2338 The influence of leisure activities on dementia prevalence in elderly Brazilian community subjects Barcelos-Ferreira, Ricardo
2011
7 4S p. S591-S592
2 p.
artikel
2339 The influence of 14-3-3 protein on the nuclear transport of SET Wang, Xiaochuan
2011
7 4S p. S585-
1 p.
artikel
2340 The interaction of beta-amyloid with alpha1-chimaerin involved in the pathogenesis of Alzheimer's disease Morimoto, Kaori
2011
7 4S p. S567-
1 p.
artikel
2341 The interdisciplinary speech therapy and art therapy and enhancing quality of life: A case study Ostroski, Rosana
2011
7 4S p. S760-
1 p.
artikel
2342 The involvement of subcortical structures in two siblings with frontotemporal dementia Koseoglu, Emel
2011
7 4S p. S729-
1 p.
artikel
2343 The LDL-R deficiency aggravates Alzheimer's-like pathology in the 5xFAD mouse model Katsouri, Loukia
2011
7 4S p. S522-
1 p.
artikel
2344 The LIFE cognition study: A multicenter trial of physical activity to prevent cognitive decline Williamson, Jeff
2011
7 4S p. S615-
1 p.
artikel
2345 The MAP kinase inhibitor drug CNI-1493 leads to cognitive improvement in an animal model of AD after 24 hours Mengel, David
2011
7 4S p. S467-
1 p.
artikel
2346 The measurement of normal and abnormal age-related declines in human cognitive function Wesnes, Keith
2011
7 4S p. S269-
1 p.
artikel
2347 The MMP/TIMP system in Alzheimer's disease Rivera, Santiago
2011
7 4S p. S813-
1 p.
artikel
2348 The Montreal cognitive assessment (MoCA) is superior to the mini-mental state examination (MMSE) in detecting patient's with moderate cognitive impairment, no-dementia (CIND) and at high risk of dementia Chen, Christopher
2011
7 4S p. S240-S241
2 p.
artikel
2349 The Montreal cognitive assessment (MoCA): Validation of alternate forms and new recommendations for education corrections Chertkow, Howard
2011
7 4S p. S157-
1 p.
artikel
2350 The mTOR pathway in Alzheimer's disease Nagy, Zsuzsanna
2011
7 4S p. S407-
1 p.
artikel
2351 The mutation P86L-CALHM1, linked to Alzheimer's disease, alters the nuclear calcium signalling Moreno-Ortega, Ana Jose
2011
7 4S p. S581-
1 p.
artikel
2352 The nature of memory failure in mild cognitive impairment: examining effect of progression and comorbid factors Villeneuve, Sylvia
2011
7 4S p. S267-S268
2 p.
artikel
2353 The neural correlates of verbal episodic memory encoding in prodromal probable Alzheimer's disease at the stage of amnestic mild cognitive impairment: An fMRI study Dannhauser, Thomas
2011
7 4S p. S72-
1 p.
artikel
2354 The neuropsychological correlates to the proportional impact of white matter hyperintensities in the patients with amnestic mild cognitive impairment in Korea Ku, Bon
2011
7 4S p. S540-
1 p.
artikel
2355 The nonclinical safety profile of the 5-HT4 partial agonist, PF-04995274, supported clinical development for symptomatic treatment of Alzheimer's disease Pettersen, Betty
2011
7 4S p. S771-
1 p.
artikel
2356 The novel tetrahydrofuranne derivative ANAVEX2-73 attenuated GSK-3ß activation and tau hyperphosphorylation in a nontransgenic Alzheimer's disease model in mice Lahmy, Valentine
2011
7 4S p. S656-S657
2 p.
artikel
2357 The Opposing Roles of Neuronal-Microglial Communication in Alzheimer’s Disease Lamb, Bruce
2011
7 4S p. S287-
1 p.
artikel
2358 Theory of mind in Alzheimer's disease Laisney, Mickael
2011
7 4S p. S275-
1 p.
artikel
2359 The overlap between the corticobasal degeneration syndrome and nonfluent aphasia Agosta, Federica
2011
7 4S p. S749-
1 p.
artikel
2360 The overlap between the corticobasal degeneration syndrome and nonfluent aphasia Agosta, Federica
2011
7 4S p. S10-S11
2 p.
artikel
2361 The pathological mechanisms leading to neurodegeneration and cell death in frontotemporal dementia Neumann, Manuela
2011
7 4S p. S805-
1 p.
artikel
2362 The peptidyl-prolyl cis/trans isomerase Pin1 affects the phosphorylation, conformation and toxicity of protein tau expressed in the yeast Franssens, Vanessa
2011
7 4S p. S585-
1 p.
artikel
2363 The PerCEN Study: Supporting Client and Care Outcomes in the Residential Dementia Care Setting. Chenoweth, Lynn
2011
7 4S p. S292-
1 p.
artikel
2364 The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in the nicotine abstinence model of cognitive dysfunction in humans Nathan, Pradeep
2011
7 4S p. e62-
1 p.
artikel
2365 The pre-dementia stage of dementia with Lewy bodies Rognve, Arvid
2011
7 4S p. S749-S750
2 p.
artikel
2366 The Prevalence of Cognitive Impairment in Older Adults With Heart Failure Blaum, Caroline
2011
7 4S p. S606-
1 p.
artikel
2367 The prevalence of underlying dementing illness contributing to the presentation of delirium in an acute hospital setting in the elderly Evans, Loretta
2011
7 4S p. S274-S275
2 p.
artikel
2368 The Projected impact of risk factor reduction on Alzheimer's disease prevalence Barnes, Deborah
2011
7 4S p. S511-
1 p.
artikel
2369 The psychosocial effects of the use of computerized cognitive stimulation on Alzheimer's patients Berenbaum, Rakel
2011
7 4S p. S642-
1 p.
artikel
2370 The quality and extent of evidence for biomarkers: a Cochrane systematic review McShane, Rupert
2011
7 4S p. S100-S101
2 p.
artikel
2371 The quality and reporting of longitudinal studies of diagnostic tests: A systematic review Noel-Storr, Anna
2011
7 4S p. e19-
1 p.
artikel
2372 The Qur'an and memory a (study of the effect of religiosity and memorizing Qur'an as a factor on memory) Al-Attas, Reem
2011
7 4S p. S641-
1 p.
artikel
2373 Therapeutic anti-Prion Monoclonal Antibody 6D11 Facilitates PrPsc Degradation in Prion Cell culture model Pankiewicz, Joanna
2011
7 4S p. S661-
1 p.
artikel
2374 Therapeutic benefits of copper-bis (thiosemicarbazonato) complexes in neurodegenerative disorders Hung, Lin
2011
7 4S p. S768-S769
2 p.
artikel
2375 Therapeutic effect of ACS84 on Parkinson's disease in 6-OHDA-induced rat model Xie, Li
2011
7 4S p. S766-
1 p.
artikel
2376 Therapeutic effect of passive immunisation with a monoclonal antibody against low molecular weight pyroglutamate oligomers in a preclinical Alzheimer mouse model Bayer, Thomas
2011
7 4S p. e54-
1 p.
artikel
2377 Therapeutic Monoclonal Antibodies against Abeta oligomers for Treatment of Alzheimer's disease Zhang, Ying
2011
7 4S p. S479-
1 p.
artikel
2378 Therapeutic potential of galantamine and memantine combination for Alzheimer's disease in scopolamine-induced amnesia models Bertorelli, Rosalia
2011
7 4S p. S121-
1 p.
artikel
2379 The regulation of caspase-3 at the synapse. Huesmann, Graham
2011
7 4S p. S380-
1 p.
artikel
2380 The regulation of tau phosphorylation and tau kinase activity by the p53 family member p73 in Alzheimer's disease animal models Cancino, Gonzalo
2011
7 4S p. S553-
1 p.
artikel
2381 The relationship between beta-amyloid protein precursor and tau in Alzheimer's disease-related iron disruption Duce, James
2011
7 4S p. S509-
1 p.
artikel
2382 The relationship between cerebral spinal fluid (CSF) biomarkers and Pittsburgh Compound B (PiB) positron emission tomography (PET) in predicting Alzheimer's disease (AD) Burns, Leah
2011
7 4S p. S206-
1 p.
artikel
2383 The relationship between educational attainment and the rate of cognitive decline in elderly Canadians depends on how one scores the 3MS: The Canadian study of health and aging (CSHA) Mukherjee, Shubhabrata
2011
7 4S p. S603-
1 p.
artikel
2384 The relationship between informant and performance-based measures of everyday function Farias, Sarah Tomaszewski
2011
7 4S p. e73-
1 p.
artikel
2385 The relationship between massed vs. spaced visuospatial and verbal learning and memory, and PiB binding status, in cognitively healthy older adults Jackson, Colleen E.
2011
7 4S p. S138-S139
2 p.
artikel
2386 The relationship between medial temporal lobe atrophy and daily activities in community-dwelling older adults Yoshida, Daisuke
2011
7 4S p. S618-
1 p.
artikel
2387 The relationship of white matter hyperintensities with perfusion and cognition in middle-aged adults at risk for Alzheimer's disease Austin, Benjamin
2011
7 4S p. e33-e34
nvt p.
artikel
2388 The Reliability and validation of the short cued recall test Youn, Jong Chul
2011
7 4S p. S271-
1 p.
artikel
2389 The retrogenesis theory to classify stages of Alzheimer's disease in a sample of the Brazilian population Da Silva, Rosimeire
2011
7 4S p. S241-S242
2 p.
artikel
2390 The Retromer Pathway Links Obesity and Diabetes to Alzheimer's Disease Small, Scott
2011
7 4S p. S283-S284
2 p.
artikel
2391 The Retrospective Analysis of a Large Data-Set Using Data-Monitoring Algorithms: What are the Logical Relationships Between the ADAS-Cog and MMSE? Yavorsky, Christian
2011
7 4S p. S177-
1 p.
artikel
2392 The Rey-Osterrieth complex figure: a standardization study Mistridis, Panagiota
2011
7 4S p. S256-
1 p.
artikel
2393 The role of adam10 in synaptic function and plasticity Luca, Monica di
2011
7 4S p. S676-S677
2 p.
artikel
2394 The role of brain macrophages on the clearance of amyloid plaques following the treatment of Tc2576 with BIIB037 Dunstan, Robert
2011
7 4S p. S700-
1 p.
artikel
2395 The role of c-Abl in the synaptotoxicity caused by Aβ oligomers: Involvement of the ephrine receptor Alvarez, Alejandra
2011
7 4S p. S589-S590
2 p.
artikel
2396 The Role of CNI-1493 in the function of primary microglia with respect to β-Amyloid Bach, Jan-Philipp
2011
7 4S p. S455-
1 p.
artikel
2397 The role of cortical thickness in memory and strategy use in older adults Babakchanian, Sona
2011
7 4S p. S416-S417
2 p.
artikel
2398 The role of cortical thickness in memory and strategy use in older adults Babakchanian, Sona
2011
7 4S p. S66-S67
2 p.
artikel
2399 The role of metallothionein and serum albumin as native metal-abeta attenuating compounds Faller, Peter
2011
7 4S p. S394-S395
2 p.
artikel
2400 The role of multivesicular bodies in Alzheimer's disease Edgar, James
2011
7 4S p. S385-
1 p.
artikel
2401 The role of neuroinflammation in the determination of regional and neuronal vulnerability in Alzheimer's disease Wenk, Gary
2011
7 4S p. S812-S813
2 p.
artikel
2402 The role of regulatory authorities in collaborative measure development Wiklund, Ingela
2011
7 4S p. S277-
1 p.
artikel
2403 The role of social support in coping with the burden of caregiving: A complex relationship Kerhervé, Hélène
2011
7 4S p. S493-S494
2 p.
artikel
2404 The social recognition test of memory in the rat: A reliable primary in-vivo cognition assay for guiding drug discovery/development decision-making relevant to neuropsychiatric diseases Virley, David
2011
7 4S p. S126-
1 p.
artikel
2405 The Souvenir II study: Rationale and study design Vellas, Bruno
2011
7 4S p. S791-
1 p.
artikel
2406 The stirling Oregon Northern Ireland cognitive stimulation (SONICS) study Thompson, Oonagh
2011
7 4S p. S677-
1 p.
artikel
2407 The Stirling Oregon Northern Ireland cognitive stimulation (SONICS) study Craig, David
2011
7 4S p. S621-
1 p.
artikel
2408 The telephone-administered minnesota cognitive acuity screen (MCAS) is sensitive to conversion from mild cognitive impairment to dementia Tremont, Geoffrey
2011
7 4S p. S547-
1 p.
artikel
2409 The therapeutic nursing interview for the purpose of the early diagnosis of Alzheimer’s disease in outpatient department Nakano, Masako
2011
7 4S p. e20-
1 p.
artikel
2410 The treviso dementia (TREDEM) study Gallucci, Maurizio
2011
7 4S p. S594-
1 p.
artikel
2411 The usefulness of amyloid-imaging in predicting the clinical outcome of patients with mild cognitive impairment Grimmer, Timo
2011
7 4S p. S212-
1 p.
artikel
2412 The use of multi-sensory therapy for dementia in residential aged care: Findings from a survey of one Australian state Rayner, Jo
2011
7 4S p. S629-
1 p.
artikel
2413 The value of dementia care mapping in evaluation Campbell, Alison
2011
7 4S p. S632-S633
2 p.
artikel
2414 The vitamin E family in Alzheimer's disease and mild cognitive impairment: Results from the AddNeuroMed study Mangialasche, Francesca
2011
7 4S p. e19-e20
nvt p.
artikel
2415 Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD Sperling, Reisa
2011
7 4S p. S377-
1 p.
artikel
2416 Thymol as a main constituent of zataria multiflora boiss: essential oil attenuates amyloid β-induced cognitive deficits in a rat model of Alzheimer's disease Majlessi, Nahid
2011
7 4S p. S770-
1 p.
artikel
2417 Time-course analysis of cerebral microhemorrhage and vascular structural changes during passive anti-amyloid beta immunotherapy in PDAPP mice Schroeter, Sally
2011
7 4S p. S527-S528
2 p.
artikel
2418 Time-line of pathology and defects in biAT mice with combined amyloid-tau pathology Kremer, Anna
2011
7 4S p. S556-
1 p.
artikel
2419 Time scales for time-to-event analyses of Alzheimer's studies Betensky, Rebecca
2011
7 4S p. S348-
1 p.
artikel
2420 Time spent on care and costs for patients with Alzheimer's disease Bellanger, Martine
2011
7 4S p. S438-
1 p.
artikel
2421 Timing and type of hormone replacement therapy and the risk of Alzheimer's disease: New findings from the cache county study Zandi, Peter
2011
7 4S p. S97-
1 p.
artikel
2422 Timing of multi-target therapy to effectively improve learning and memory in ovariectomized rats Zhang, Qi
2011
7 4S p. S671-
1 p.
artikel
2423 To explore the manifestation of dementia's neuropsychiatric symptoms in daily activities and strategy implementation via a consultation clinic Chang, Ling-Hui
2011
7 4S p. e49-e50
nvt p.
artikel
2424 TOMM40, APOE and preclinical memory decline Caselli, Richard
2011
7 4S p. S293-
1 p.
artikel
2425 TOMM40 “523” Genotype Affects Age of Alzheimer’s Disease Onset Differentially by Race Hayden, Kathleen
2011
7 4S p. S186-
1 p.
artikel
2426 TOMM40 Poly-T Length Variant and Age-At-Onset in Familial AD Caused by PSEN1 and PSEN2 Mutation Li, Gail (Ge)
2011
7 4S p. S189-
1 p.
artikel
2427 TOMM40 Poly-T Variants Influence Sensitivity to Lorazepam-Induced Impairment in Healthy Elderly Pomara, Nunzio
2011
7 4S p. S192-S193
2 p.
artikel
2428 TOMM40 rs2075650, TOMM40 rs157580 and TOMM40 PolyT polymorphism effects on ventricular enlargement in individuals with and without mild cognitive impairment Babakchanian, Sona
2011
7 4S p. S47-
1 p.
artikel
2429 TOMM40 rs2075650, TOMM40 rs157580 and TOMM40 PolyT Polymorphism Effects on Ventricular Enlargement in Individuals with and Without Mild Cognitive Impairment Babakchanian, Sona
2011
7 4S p. S178-
1 p.
artikel
2430 Topographical Markers of Alzheimer's Disease Progression: Can MRI and FDG-PET Serve as Surrogate Outcomes in Clinical Trials of Disease Modifying Agents in Alzheimer's Disease? Jicha, Gregory
2011
7 4S p. S1-
1 p.
artikel
2431 Towards a comprehensive analysis of the role of inflammatory mediators on Alzheimer's like pathology in pre-clinical mouse models Chakrabarty, Paramita
2011
7 4S p. S413-S414
2 p.
artikel
2432 Towards a model of sporadic Alzheimer's disease: Aiding design of small molecule TrkA agonists Watson, Judy
2011
7 4S p. S802-
1 p.
artikel
2433 Towards more strategic subject selection in Alzheimer's randomized clinical trials: neuropsychological testing to distinguish fast decliners from improvers Veroff, Amy
2011
7 4S p. S276-S277
2 p.
artikel
2434 Toward therapeutic system for Alzheimer's Disease by removal of blood Aβ: Hemodialysis improved the impaired cognitive states of renal failure patients Kitaguchi, Nobuya
2011
7 4S p. S463-
1 p.
artikel
2435 Tracking progression from mild cognitive impairment to Alzheimer's disease using multivariate biomarkers and pattern classification Wen, Wei
2011
7 4S p. S133-S134
2 p.
artikel
2436 Tracking progression with serial MRI in the language variants of frontotemporal lobar degeneration Rohrer, Jonathan
2011
7 4S p. S222-
1 p.
artikel
2437 Training family physicians and primary care nurses improves diagnostic assessment of dementia: results of a randomized controlled trial Perry, Marieke
2011
7 4S p. S498-
1 p.
artikel
2438 Train the trainer in dementia care: Results of a program fostering long-term enhancement and implementation of communication skills in nursing home staff caring for dementia patients Franzmann, Judith
2011
7 4S p. S446-
1 p.
artikel
2439 Trajectory of white matter hyperintensity burden preceding mild cognitive impairment Silbert, Lisa
2011
7 4S p. S7-
1 p.
artikel
2440 Trajectory of white matter hyperintensity burden preceding mild cognitive impairment Silbert, Lisa
2011
7 4S p. S224-
1 p.
artikel
2441 Transcriptional Dysregulation in Alzheimer's disease Paudel, Hemant
2011
7 4S p. S557-
1 p.
artikel
2442 Transcriptional dysregulation of SIRT3 is driven by impaired Sp4 activity in Alzheimer's disease Ryu, Hoon
2011
7 4S p. S684-
1 p.
artikel
2443 Transcriptional profile of a neuronally enriched region of CA1 as a function of progressing Alzheimer's disease Blalock, Eric
2011
7 4S p. S698-S699
2 p.
artikel
2444 Transgenic mouse models with increased pyroglutamate-abeta formation show early phenotypic changes Schilling, Stephan
2011
7 4S p. S410-
1 p.
artikel
2445 Transition of brain structural changes in relation to cognitive decline in Alzheimer's disease: evidence from the Alzheimer's Disease Neuroimaging Initiative Song, Xiaowei
2011
7 4S p. S38-
1 p.
artikel
2446 Transition of brain structural changes in relation to cognitive decline in Alzheimer's disease: evidence from the Alzheimer's Disease Neuroimaging Initiative Song, Xiaowei
2011
7 4S p. S225-
1 p.
artikel
2447 Translational receptor occupancy for the 5-HT4 partial agonist PF-04995274 in rats, non-human primates and healthy volunteers Grimwood, Sarah
2011
7 4S p. S653-
1 p.
artikel
2448 Transmembrane protein X in early stages of Alzheimer's disease Del Campo Milan, Marta
2011
7 4S p. e12-e13
nvt p.
artikel
2449 Transmission and Spreading of Tauopathy In Transgenic Mouse Brain Tolnay, Markus
2011
7 4S p. S491-S492
2 p.
artikel
2450 Trans-synaptic degeneration following acute axonal severing and beta-amyloid deposits in reconstructed neuronal networks Deleglise, Bérangère
2011
7 4S p. S589-
1 p.
artikel
2451 Traumatic brain injury and risk of dementia in older veterans Barnes, Deborah
2011
7 4S p. S347-
1 p.
artikel
2452 Treatment effects on hippocampal degeneration in dementia of the Alzheimer type Csernansky, John
2011
7 4S p. S374-S375
2 p.
artikel
2453 Treatment of Alzheimer's disease with transdermal rivastigmine: The role of preceding and concomitant medication Articus, Konstantin
2011
7 4S p. S777-
1 p.
artikel
2454 Treatment of experimental autoimmune encephalomyelitis by antioxidants (experimental study) Sanikidze, Tamar
2011
7 4S p. e11-
1 p.
artikel
2455 Treatment of experimental autoimmune encephalomyelitis by antioxidants (experimental study) Sanikidze, Tamar
2011
7 4S p. e11-
1 p.
artikel
2456 Treatment of mice with tyrosine kinase inhibitors (TKI) such as Gleevec lowers plasma levels of amyloid beta peptides (Abeta) in mice Weksler, Marc
2011
7 4S p. e67-
1 p.
artikel
2457 Treatment of 5XFAD transgenic mice with Ibuprofen Hillmann, Antje
2011
7 4S p. S461-
1 p.
artikel
2458 Trehalose enhances the degradation of Tau through the autophagy pathway Krueger, Ulrike
2011
7 4S p. S556-
1 p.
artikel
2459 Trehalose protects from aggravation of amyloid pathology induced by isoflurane anesthesia in APPswe mutant mice Perucho, Juan
2011
7 4S p. S523-S524
2 p.
artikel
2460 Trends in dementia occurrence in a 15-year period in central Stockholm, Sweden Qiu, Chengxuan
2011
7 4S p. S361-S362
2 p.
artikel
2461 Trends in the prevalence of dementia in Japan: a preliminary report Ikejima, Chiaki
2011
7 4S p. S596-
1 p.
artikel
2462 Triple neurodegeneration in a dementia/parkinsonism patient - case report Trošt, Maja
2011
7 4S p. S709-
1 p.
artikel
2463 Trisomy for Synaptojanin1 in Down’s Syndrome is Functionally Linked to the Enlargement of Early Endosomes, the First Morphological Evidence of Alzheimer’s Disease Lavaur, Jeremie
2011
7 4S p. S188-S189
2 p.
artikel
2464 TrkB alternative transcript expression in Alzheimer's disease Wong, Jenny
2011
7 4S p. S571-
1 p.
artikel
2465 TrkB isoforms differentially regulate amyloid precursor protein Swedish mutant glycosylation and processing Ansaloni, Sara
2011
7 4S p. S579-
1 p.
artikel
2466 Tudca, a bile acid, attenuates amyloid beta deposition and rescues memory deficits in app/ps1 mice Nunes, Ana
2011
7 4S p. S468-S469
2 p.
artikel
2467 Tutoral issues in Brazilian version of MoCA test Sarmento, Ana Luisa
2011
7 4S p. S264-
1 p.
artikel
2468 Twins discordant for neuropsychologically-defined MCI: Relationship to premorbid cognitive ability Franz, Carol
2011
7 4S p. S536-S537
2 p.
artikel
2469 TXNIP, the major player in insulin resistance, is early over-expressed in the brain of the 5XFAD Alzheimer's mice model and is induced by Aβ in vitro: Emerging role of TXNIP and inflammation in Alzheimer's Disease progression Gouget, Tiphany
2011
7 4S p. S684-
1 p.
artikel
2470 Type 2 diabetes, but not hypercholesterolemia, is related to decrements in cognitive functioning among patients with MCI Kukic, Vlatka
2011
7 4S p. S273-S274
2 p.
artikel
2471 Tyr 682 on APP intracellular domain modulates NGF signaling Matrone, Carmela
2011
7 4S p. S583-
1 p.
artikel
2472 Ultra-high field 7-Tesla hippocampal imaging: A semi-automated method for measuring stratal width Kerchner, Geoffrey
2011
7 4S p. S718-S719
2 p.
artikel
2473 Ultra-high field 7-tesla hippocampal imaging: A semi-automated method for measuring stratal width Kerchner, Geoffrey
2011
7 4S p. S60-
1 p.
artikel
2474 Ultrastructural analysis of the dark neuron formation during experimental endotoxemia: Implications for Alzheimer's disease Gasimov, Eldar
2011
7 4S p. S711-
1 p.
artikel
2475 Under-provision of medical care for people with dementia in primary care Connolly, Amanda
2011
7 4S p. S631-
1 p.
artikel
2476 Understanding and control of normal ageing can help us better withstand non-inherited cases of Alzheimer's disease Khalyavkin, Alexander
2011
7 4S p. e46-
1 p.
artikel
2477 Understanding anosognosia in Alzheimer's patients Volpi, Leda
2011
7 4S p. S268-
1 p.
artikel
2478 Understanding the cognitive benefits of a sculpture garden for patients with Alzheimer's disease and their families: A feasibility study Mair, Carolyn
2011
7 4S p. S628-
1 p.
artikel
2479 Understanding the impact of estrogen receptor beta activation in the brain Liu, Feng
2011
7 4S p. S671-
1 p.
artikel
2480 Understanding the support needs of young-onset dementias: experience from a UK tertiary referral clinic Judd, Katy
2011
7 4S p. S89-
1 p.
artikel
2481 Understanding the value of positive staff-family relationships in the Australian residential aged care setting: exploring the impact of attitudes and beliefs of staff and families on quality of relationships Fetherstonhaugh, Deirdre
2011
7 4S p. S448-S449
2 p.
artikel
2482 Unique brain PK properties of 3D6 and bapineuzumab depend on cerebral amyloid load in PDAPP transgenic mice Bard, Frederique
2011
7 4S p. e54-
1 p.
artikel
2483 Unobtrusive measurement of computer use to assess mild cognitive impairment Kaye, Jeffrey
2011
7 4S p. S683-
1 p.
artikel
2484 Upregulation of endocytic proteins in aged Tg2576 mice Thomas, Rhian S.
2011
7 4S p. S117-
1 p.
artikel
2485 Urinary glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1 activity and cognitive function and decline in community dwelling elderly Chan, Ngar Yu
2011
7 4S p. S132-
1 p.
artikel
2486 Usability assessment of a psycho-educational website for Alzheimer's disease caregivers Cristancho-Lacroix, Victoria
2011
7 4S p. S430-
1 p.
artikel
2487 Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Ayutyanont, Napatkamon
2011
7 4S p. S373-S374
2 p.
artikel
2488 Use of an fdg-pet-derived hypometabolic convergence index enrichment strategy to reduce sample sizes in alzheimer's disease clinical trials: Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Ayutyanont, Napatkamon
2011
7 4S p. S43-
1 p.
artikel
2489 Use of CSF biomarkers in clinical trials: The ADNI experience Shaw, Leslie
2011
7 4S p. S674-
1 p.
artikel
2490 Use of informant-reported web-based data collection to assess dementia symptoms: Validation in relation to the dependence scale Rockwood, Kenneth
2011
7 4S p. S499-
1 p.
artikel
2491 Use of pons as a normalizing region for [C-11]PIB PET scans: Effect on subject classification Lopresti, Brian
2011
7 4S p. S721-
1 p.
artikel
2492 Use of PONS as a normalizing region for [c-11]pib-pet scans: Effect on subject classification Lopresti, Brian
2011
7 4S p. S61-
1 p.
artikel
2493 Using ambient assisted living infrastructures to monitor emotional change: Applications in supporting dementia interventions Knapp, R. Benjamin
2011
7 4S p. S679-
1 p.
artikel
2494 Using ambient assisted living infrastructures to monitor emotional change: Applications in supporting dementia interventions Knapp, Ben
2011
7 4S p. S438-
1 p.
artikel
2495 Using DTI for non-invasive evaluation of axonal damage caused by exposure of axon terminals to amyloid beta Sun, Shu-Wei
2011
7 4S p. S309-S310
2 p.
artikel
2496 Using in silico mechanistic disease modeling to address the effect of amyloid beta manipulation on cognitive clinical readouts Geerts, Hugo
2011
7 4S p. S774-S775
2 p.
artikel
2497 Using technology to maximize the quality of life of people with dementia in adult day centers, assisted living facilities and nursing homes Edelman, Perry
2011
7 4S p. S499-S500
2 p.
artikel
2498 Using the CANTAB computerized battery to discriminate mild cognitive impairment and dementias Hammers, Dustin
2011
7 4S p. S537-
1 p.
artikel
2499 Utility of barrat scale to measure impulsivity in a series of cases with behavioral variant-frontotemporal lobar degeneration (bv-FTD) Gil Moreno, María Jose
2011
7 4S p. S274-
1 p.
artikel
2500 Utility of the Measurement of Ventilatory Response to Hypercapnia as a Means of Diagnostic Method of Depression that Precedes Dementia with Lewy Bodies Takahashi, Sho
2011
7 4S p. S167-
1 p.
artikel
2501 Utilization of Direct Medical Care and Support Services of Alzheimer's Disease Patients by Type of Caregiver Mucha, Lisa
2011
7 4S p. S432-
1 p.
artikel
2502 Vagus somatosensory-evoked potentials: a non-invasive diagnostic possibility for patients with mild cognitive impairment? Metzger, Florian
2011
7 4S p. S541-S542
2 p.
artikel
2503 Validation of a midlife dementia risk score in a large diverse population Exalto, Lieza
2011
7 4S p. S504-
1 p.
artikel
2504 Validation of an internationally developed protocol to assess the distribution and severity of cerebral amyloid angiopathy in the post-mortem brain Love, Seth
2011
7 4S p. e76-
1 p.
artikel
2505 Validation of K-ACE to diagnose Alzheimer's disease and MCI in the Korean elderly Heo, Jae-Hyeok
2011
7 4S p. S246-S247
2 p.
artikel
2506 Validation of the Amsterdam IADL questionnaire ®, a new tool to measure instrumental activities of daily living Sikkes, Sietske
2011
7 4S p. S454-
1 p.
artikel
2507 Validation of the rat pharmacodynamic model for amyloid-beta peptide lowering agents Permanne, Bruno
2011
7 4S p. S124-
1 p.
artikel
2508 Validation of the Turkish version of the Addenbrooke's cognitive examination in Turkey Mihci, Ebru
2011
7 4S p. S162-
1 p.
artikel
2509 Validity study of the Montreal cognitive assessment in patients with vascular dementia Santana, Isabel
2011
7 4S p. S264-
1 p.
artikel
2510 Valproic Acid increases alpha-synuclein expression by non-transcriptional regulation in rat primary astrocytes Han, Seol-Heui
2011
7 4S p. S671-
1 p.
artikel
2511 Valproic acid prevents hemin toxicity through HO-1 downregulation by regulating a ubiquitin-proteosomal pathway Moon, Yeonsil
2011
7 4S p. e48-
1 p.
artikel
2512 Variability in trajectory of estimated glomerular filtration rate is associated with risk of dementia O'Hare, Ann
2011
7 4S p. S297-
1 p.
artikel
2513 Variable effects of the gamma-secretase inhibitor ELND006 on Aβ across different compartments (brain, ISF, CSF, and plasma) following sustained exposure via subcutaneous osmotic pumps in wild-type mice Brigham, Elizabeth
2011
7 4S p. S313-S314
2 p.
artikel
2514 Vascular and Alzheimer's Disease pathologies in relation to cognitive decline: Data from the Einstein Aging Study Autopsy series Derby, Carol
2011
7 4S p. S350-
1 p.
artikel
2515 Vascular dementia with left thalamic infarction linked to decreased word fluency and a depressive state through the thalamo-cortical network: the Osaki-Tajiri Project Akanuma, Kyoko
2011
7 4S p. e76-
1 p.
artikel
2516 Vascular Disease Risk Factors and Alzheimer's Disease Skoog, Ingmar
2011
7 4S p. S284-
1 p.
artikel
2517 Vascular disorder and oxidative stress in mild cognitive impairment Viola, Stefano
2011
7 4S p. S549-
1 p.
artikel
2518 Vascular inflammation and leukocyte trafficking in an experimental model of Alzheimer's disease Zenaro, Elena
2011
7 4S p. S416-
1 p.
artikel
2519 Vascular Risk and Amyloid Deposition: Findings from the AIBL Study of Aging Yates, Paul
2011
7 4S p. S285-
1 p.
artikel
2520 Vascular risk factors are associated with cognitive decline in mild cognitive impairment Lorius, Natacha
2011
7 4S p. S597-
1 p.
artikel
2521 Vasogenic edema in immunotherapy: Sign of efficacy or danger Salloway, Stephen
2011
7 4S p. S806-S807
2 p.
artikel
2522 Vasogenic edema in the setting of ß-amyloid lowering therapy, adverse event: what is it and how is it detected? Barakos, Jerome
2011
7 4S p. e75-
1 p.
artikel
2523 Ventral and dorsal visual streams in posterior cortical atrophy Migliaccio, Raffaella
2011
7 4S p. S76-
1 p.
artikel
2524 Ventral and dorsal visual streams in posterior cortical atrophy Migliaccio, Raffaella
2011
7 4S p. S740-S741
2 p.
artikel
2525 Verbal fluency performances underpinned by white matter alterations: multimodal imaging in French elderly agricultural subjects Pelletier, Amandine
2011
7 4S p. S424-
1 p.
artikel
2526 Verbal memory associations with cortical thickness Babakchanian, Sona
2011
7 4S p. S19-
1 p.
artikel
2527 Very mild subcortical vascular dementia (CDR 0.5) has severer apathy than very mild Alzheimer's disease (CDR 0.5) in a community: The Kurihara project Nakamura, Kei
2011
7 4S p. S543-
1 p.
artikel
2528 Visual attentional assessment in Mild Cognitive Impairment and Alzheimer's disease: relationship to interhemispheric metabolic imbalances Redel, Petra
2011
7 4S p. S294-
1 p.
artikel
2529 Visualising the emergence of posterior cortical atrophy Kennedy, Jonathan
2011
7 4S p. S161-S162
2 p.
artikel
2530 Visual presentation of regional volumetry data for diagnostic decision support in Alzheimer's disease MR imaging Heckemann, Rolf
2011
7 4S p. e18-
1 p.
artikel
2531 Visual rating of hypointensities in the brain using susceptibility-weighted Imaging; a pilot study Van der Flier, Wiesje
2011
7 4S p. S729-S730
2 p.
artikel
2532 Visual rating versus volumetric analysis of brain MRI for the diagnosis of prodromal and probable Alzheimer's Disease Potter, Elizabeth
2011
7 4S p. S338-
1 p.
artikel
2533 Visual variant of alzheimer's disease in an algerian patient Elias, Attal
2011
7 4S p. S533-
1 p.
artikel
2534 Visuo-perceptual task performance in dementia with Lewy bodies Edgar, Christopher
2011
7 4S p. S242-S243
2 p.
artikel
2535 Vitamin D in elderly psychiatric inpatients Lapid, Maria I.
2011
7 4S p. S140-
1 p.
artikel
2536 Voluntary exercise in THY-Tau22 mice prevents tau pathology and its consequences Buée-Scherrer, Valérie
2011
7 4S p. S516-
1 p.
artikel
2537 Voxel-based detection of tract-based white matter abnormalities in Alzheimer disease Juh, Rahyeong
2011
7 4S p. S13-
1 p.
artikel
2538 Walking in late middle age and prevalence of dementia in centenarians in the monzino 80-plus study Tettamanti, Mauro
2011
7 4S p. S365-
1 p.
artikel
2539 48-week efficacy and tolerability of treatment with SB-742457, a novel 5HT6 receptor antagonist, when added on to donepezil in subjects with mild-to-moderate Alzheimer's disease (AD) Maher-Edwards, Gareth
2011
7 4S p. e5-
1 p.
artikel
2540 What are key factors that promote continued participation in Alzheimer's disease prevention studies? Jacobson, Laura
2011
7 4S p. e46-
1 p.
artikel
2541 What can homing pigeons tell us about navigational impairments in Alzheimer’s patients? Jorge, Paulo
2011
7 4S p. S119-
1 p.
artikel
2542 What can we learn about the concept and underlying biology of intermediate cognition from the longstanding population based cohort CFAS Brayne, Carol
2011
7 4S p. S534-S535
2 p.
artikel
2543 What Factors Might Prevent Dementia? Larson, Eric
2011
7 4S p. S83-
1 p.
artikel
2544 What is required to ensure quality dementia care in rural settings? Forbes, Dorothy
2011
7 4S p. S638-
1 p.
artikel
2545 What is the Potential for Delaying Alzheimer’s Disease by Vascular Risk Factor Reduction? Lautenschlager, Nicola
2011
7 4S p. S285-
1 p.
artikel
2546 When are Alzheimer's Disease risk factors most hazardous? AD prediction in the Aberdeen 1921 birth cohort Whalley, Lawrence
2011
7 4S p. S367-S368
2 p.
artikel
2547 When higher activations reflect lower deactivations: A PET study in Alzheimer's disease during encoding and retrieval in episodic memory Bejanin, Alexandre
2011
7 4S p. S730-S731
2 p.
artikel
2548 When higher activations reflect lower deactivations: a PET study in Alzheimer's disease during encoding and retrieval in episodic memory Bejanin, Alexandre
2011
7 4S p. S70-S71
2 p.
artikel
2549 Which attributes of tau mediate toxicity: Phosphorylation or aggregation? Cowan, Catherine
2011
7 4S p. S554-
1 p.
artikel
2550 Which biomarkers are useful in predicting converters to Alzheimer's Disease from MCI at 12 or 36 months from baseline? Barnes, Josephine
2011
7 4S p. S129-
1 p.
artikel
2551 Which cognitive function is influenced by vitamin D among older high-functioning community-dwellers? Annweiler, Cedric
2011
7 4S p. S590-S591
2 p.
artikel
2552 White matter damage in frontotemporal lobar degeneration spectrum Agosta, Federica
2011
7 4S p. S712-
1 p.
artikel
2553 White matter damage in frontotemporal lobar degeneration spectrum Agosta, Federica
2011
7 4S p. S18-S19
2 p.
artikel
2554 White matter hyperintensity exacerbates cortical gray matter volume reduction in Alzheimer's disease: A voxel-based morphometric study Youn, Young Chul
2011
7 4S p. S747-
1 p.
artikel
2555 White matter integrity and intraindividual variability in aging and early-stage Alzheimer disease Head, Denise
2011
7 4S p. S736-
1 p.
artikel
2556 White matter integrity in first-episode late-onset depression using tract-based spatial statistics Wang, Huali
2011
7 4S p. S227-
1 p.
artikel
2557 White matter lesion effect on tract-based spatial statistics for Alzheimer's patients Wang, Huali
2011
7 4S p. S746-
1 p.
artikel
2558 White matter lesions in familial Alzheimer's disease: evidence for influence of mutation position on amyloid angiopathy? Ryan, Natalie
2011
7 4S p. S235-S236
2 p.
artikel
2559 White-matter T2-hyperintensities without lacunar infarcts are associated with cognitive impairment but not with dementia in CADASIL Benisty, Sarah
2011
7 4S p. S750-
1 p.
artikel
2560 White matter tract abnormalities in mild to moderate Alzheimer's disease revealed by region-of-interest analyses of diffusion tensor imaging Keihaninejad, Shiva
2011
7 4S p. S50-S51
2 p.
artikel
2561 Whole-brain and ventricular volume change measurement in multicenter clinical trials: A feasibility study of Jacobian integration using ADNI data Belaroussi, Boubakeur
2011
7 4S p. S19-S20
2 p.
artikel
2562 Whole-brain and ventricular volume change measurement in multicenter clinical trials: A feasibility study of Jacobian Integration using ADNI data Belaroussi, Boubakeur
2011
7 4S p. S204-
1 p.
artikel
2563 Whole brain atrophy and spatiotemporal gait parameters during dual-task gait Doi, Takehiko
2011
7 4S p. S609-S610
2 p.
artikel
2564 Whole brain structural changes predict the mild cognitive impairment to Alzheimer's disease conversion: Evidence from the Alzheimer's Disease Neuroimaging Initiative Zhang, Ningnannan
2011
7 4S p. S18-
1 p.
artikel
2565 Whole Brain Structural Changes Predict The Mild Cognitive Imparirment to Alzheimer's Disease Conversion: Evidence from the Alzheimer's Disease Neuroimaging Initiative Zhang, Ningnannan
2011
7 4S p. S344-
1 p.
artikel
2566 Whole transcriptome changes in the prefrontal cortex of late-onset Alzheimer's disease patients Humphries, Crystal
2011
7 4S p. S94-S95
2 p.
artikel
2567 Who refuses diagnostic assessment for dementia? Fowler, Nicole
2011
7 4S p. S451-S452
2 p.
artikel
2568 Whose Mutation is It? Beattie, B. Lynn
2011
7 4S p. S179-
1 p.
artikel
2569 Why do Alzheimer's disease patients have more ideological and sociolinguistic lexical items preserved?: Improving communication between patients and caregivers Alegria, Renne
2011
7 4S p. S622-
1 p.
artikel
2570 Wii sports, a usability study with MCI and Alzheimer's patients Legouverneur, Grégory
2011
7 4S p. S500-S501
2 p.
artikel
2571 Willingness to Pay for Alzheimer’s Disease Genetic Susceptibility Testing: Results from the REVEAL Study Kopits, Ilona
2011
7 4S p. S185-
1 p.
artikel
2572 Word and letter processing in the visual variant of Alzheimer's disease Yong, Keir
2011
7 4S p. S270-S271
2 p.
artikel
2573 Working memory binding: a cognitive marker for Alzheimer's disease Parra, Mario
2011
7 4S p. S294-S295
2 p.
artikel
2574 Working memory binding and dual-tasking can mark onset and progression of Alzheimer's disease Moreno, Sonia
2011
7 4S p. S257-
1 p.
artikel
2575 20 year trajectories of cognition among elderly women who develop cognitive impairment Thibodeau, Marie-Pierre
2011
7 4S p. S365-
1 p.
artikel
2576 Young expanded lesion than elder since early stage in Alzheimer's disease Watanabe, Chigusa
2011
7 4S p. e44-
1 p.
artikel
2577 Zebrafish model of vascular changes in Alzheimer's disease Ethell, Doug
2011
7 4S p. S100-
1 p.
artikel
2578 Zinc provides protection against aluminum-induced neurodegeneration Singla, Neha
2011
7 4S p. S617-
1 p.
artikel
                             2578 gevonden resultaten
 
<< vorige   
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland